BTIG Raises Carlsmed Price Target to $26
The target implies substantial upside from the posted price, but this is a single analyst opinion and the record provides no supporting rationale.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target implies substantial upside from the posted price, but this is a single analyst opinion and the record provides no supporting rationale.
What happened, with direct paths to the underlying reporting
BTIG raised its price target for Carlsmed (CARL) to $26, compared with the posted price of $14.71. This is a bullish analyst opinion, not a guarantee of future performance.
Target: $26
Posted price: $14.71
Analyst firm: BTIG
Analyst: Ryan Zimmerman
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.